Fosun International LTD Argenx Se Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$113.31 - $150.51 $6.97 Million - $9.25 Million	-61,483 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$115.0 - $141.58 $894,470 - $1.1 Million	7,778 Added 14.48%	61,483 $8.47 Million
Q1 2019 May 10, 2019	BUY	$98.85 - $134.59 $2.11 Million - $2.87 Million	21,300 Added 65.73%	53,705 $6.69 Million
Q4 2018 Jan 31, 2019	BUY	$63.81 - $109.82 $2.07 Million - $3.56 Million	32,405 New	32,405 $3.11 Million

435

29.2M

390K

272K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.